She spent two years working in film production management, first at Creative Artists Agency in Los Angeles, and then at Kennedy/Marshall Co., the company that produced E.T.. But how CEO Sarah London decides to move the company. "I am delighted that the Board has appointed Sarah as CEO. I'm thrilled to be part of this management team, and I firmly believe in the potential of this Company to continue its remarkable history of accomplishment within the healthcare industry.". By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Net income dropped 26% to $1.3 billion. Centene.com uses cookies. Effective September 7, 2021, the Board of Directors (the "Board") of Centene Corporation (the "Company") elected Sarah M. London as Vice Chairman of the Board of Directors of Centene Corporation and Brent D. Layton as the Company's President and Chief Operating Officer. The board of Centene has picked Sarah London an executive with roots in venture capital and talent management to succeed Michael Neidorff as the companys CEO. is attached hereto as Exhibit 99.1 and incorporated herein by reference. Chicago/NYC. Drew Asher. ST. LOUIS, March 22, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. Dec 5, 2022. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully; restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. And Centene has expanded into the business of Medicare Advantage, the privatized health benefits myriad health insurers offer senior via contract with the federal government. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. YEAR. I'm excited by the tremendous opportunity to leverage the size and scale of this Company to create true, sustaining value for our members, state partners, employees and shareholders.". Big Jumps In Diversity Fuel Surge In U.S. Tennis Participation Since 2020, Walgreens-Backed VillageMD Buys 30-Location Physician Group In Connecticut, Banning Abortion Pill Mifepristone Would Set A Dangerous Precedent For The Politicization Of Public Health, Ukraine Wars Toll Of Death, Destruction, Displacement, And Trauma: Fresh Evidence Of Systematic Planning Of Torture Leaves Behind An Indelible Mark, Walmart To Double Health Clinic Footprint As Amazon And Rivals Buy Doctor Offices, Covid-19s Enormous Death Toll: Worldwide Life Expectancy Has Experienced A Steep Decline, Questions Scientists Should Now Explore With Respect To Covid-19, Sustainable Development A Smart Solution for Africa and the Middle East, And less than a month ago, Centene said Neidorff. President. In their new roles, Ms. London and Mr. Layton will each report to . Published Mar 22, 2022 < 1 minute read. Jan 3, 2023 09:43pm. All forward-looking statements included in this press release are based on information available to us on the date hereof. You may opt-out by. Centene Corporation, a Fortune 25 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. Centene Corporation, a Fortune 25 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. Sarah London | 2022 Most Powerful Women. Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Biography. View original content:https://www.prnewswire.com/news-releases/centene-appoints-sarah-london-as-chief-executive-officer-301508299.html, https://www.prnewswire.com/news-releases/centene-appoints-sarah-london-as-chief-executive-officer-301508299.html, Ukraine Latest: Saudi Generators Sent; Bakhmut Battles Continue, Pot vote has Oklahoma hungry to rake in green from Texas, How Ron DeSantis misreads Corporate America, Tesla recalls 3,470 Model Y vehicles over loose bolts, 3 big things in investing you might have missed this week. We have a unique opportunity to empower our members, providers, and their communities in this transformation.. Centene Corporation announced that Sarah London, vice chairman of Centene, has been appointed chief executive officer, effective immediately, succeeding Michael Neidorff. Prior to joining Humedica, Ms. London was part of the team that launched Accretive Health's Quality & Total Cost of Care business, providing end-to-end population health strategy and operational consulting to leading medical centers around the country. Her focus has been advancing integrated, value-based care models through the development and application of data-driven insights and technology. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. Centene Corporation, (d) Election of Sarah London as a Member of the Board, ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. Women represent 76% of our employees and 65% of employees in supervisory positions. In 2010, she helped start a health care cost and quality data business for Accretive Health, a medical billing and debt collection company. ", Drew Asher, Centene's Chief Financial Officer, said, "Sarah brings a modern vision to the helm of one of this country's most important healthcare companies. Since Mr. Neidorff began a medical leave of absence in February 2022, she has been a member of the Office of the Chairman charged with running the day-to-day management of the Company. CB Rank (Person) 87,126. There are 29 older and 1 younger executives at Centene. London has spent her career at the forefront of innovation . Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, after the date hereof. Brent Layton, President and Chief Operating Officer of Centene, stated, "Sarah brings a tremendous skillset to the leadership of Centene Corporation, and I'm excited to partner closely with her as Centene begins our journey into the next era of our history. Biography. While at Optum Ventures, she oversaw investments in companies such as IDx, a startup that uses artificial intelligence to detect diabetic retinopathy, and Apervita, a health care quality data company. Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Centene Board of Directors. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. Ms. London previously served as Vice President of Client Services & Operations with Humedica, a venture-backed healthcare data and analytics company acquired by Optum in 2013. Biography. Neidorff was the Clayton, Missouri-based health insurance giants chairman as well as its CEO. Employees in the business development department receive relatively high salaries as well, where wages average $91,494 per year. Magna Cum Laude in History & Literature from Harvard College, where she played Division I tennis. Sarah London, vice chairman of the board of directors at Centene (NYSE: CNC), has accepted additional responsibilities as CEO of the St. Louis-based health insurer. Environmental, Social and Governance (ESG), HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American, CENTENE TO PRESENT AT BARCLAYS 2023 GLOBAL HEALTHCARE CONFERENCE, Centene Addresses Social Isolation in Schools with National No One Eats Alone Day. New SEC Custody Rule Would Scare Away Qualified Custodians: Lawyer, Why Secure 2.0s RMD Delay Matters Even More Than Many Think, Long COVID Correlates With High Mortality: Health Insurer, Antitrust Suit Challenging Schwab-TD Ameritrade Deal Can Proceed, Judge Rules, When Medicare Enrollees Return to Work: A Medicare Customer Q&A, How to Attract the Best, Most Overlooked Clients, Divorce Looks Like Forced Early Retirement for Many Wealthy Women, Advisor Says, Advisor Speaks Out on Industry's Treatment of Women. Managed care members jumped 1.1 million to 26.6 million. We salute the Veterans and members of military families who have joined our team. In announcing the 41-year-old Londons elevation to Centenes top job, the company described her as at the forefront of innovation in healthcare . Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Ms. London previously served as Vice President of Client Services & Operations with Humedica, a venture-backed healthcare data and analytics company acquired by Optum in 2013. Insiders trading at Centene Over the last 19 years, insiders at Centene have traded over $220,031,916 worth of Centene stock and bought 89,005 units worth $5,026,837 . Clayton-based Centene Corp. has appointed its vice board chair Sarah London as its new CEO. Subscriber only . Since then Sarah has changed 3 companies and 3 roles. She said about her new role that the health care landscape is changing rapidly. Sarah London Age : 42 Public asset : 24,128,130 USD Country of residence : Unknown Linked companies : Centene Corporation Biography of Sarah London Presently, Sarah London is President-Health Care Enterprises at Centene Corp. Centene CEO Sarah London joined CNBC 's Power Lunch with Bertha Coombs to discuss Centene's local approach as a differentiator, its data-driven strategies to enhance health outcomes, and. 1. The salaries that employees earn in Centene can be influenced by the department or organization function that they work in. .advancing integrated, value-based care models through the development and application of data-driven insights and technology. Londons promotion to CEO is effective immediately, Centene said. Ms. London has spent her career at the forefront of innovation in healthcare. He continues to be the chairman. Centene, which sells an array of government subsidized health insurance including Obamacare, has been working for much of this year on a permanent successor to Neidorff, who in December announced his plan to retire later this year.London takes over a company that is a national player among the biggest . To no one's great surprise, the pick is Sarah London, formerly vice chair of the Centene board of directors, one-third of their 'value creation office', and part of the Office of the . Over the last 19 years, insiders at Centene have traded over $220,031,916 worth of Centene stock and bought 89,005 units worth $5,026,837 Centene ( NYSE: CNC) said it had appointed Sarah London to succeed Michael Neidorff as the Chief . The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Michael Neidorff made it on to this list in 2017 in 17th position. ", This is a BETA experience. Michael built one of the great success stories in American business, and his commitment to providing affordable, high-quality healthcare to our fellow citizens will remain a bedrock of this Company going forward," said Ms. London.

Five Supporting Details In The Golden Age Of Comics, Articles S